Decentralized Trial Wearable Kit Global Market Report 2025

The decentralized trial wearable kit market size has grown rapidly in recent years. It will grow from $2.39 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 19.4%. The growth during the historic period can be attributed to the increasing integration of wearable sensors with digital platforms, rising emphasis on patient-centric trial designs, growing adoption of smartphones and wearables, increasing demand for better patient adherence and engagement, and the rising need for remote monitoring in emerging markets.

The decentralized trial wearable kit market size is expected to see rapid growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to the rising awareness of data-driven clinical trials, increasing collaboration between technology companies and pharmaceutical firms, growing prevalence of chronic diseases leading to higher demand for continuous monitoring, rising adoption of wearable biosensors, and expanding healthcare digitization initiatives. Major trends anticipated during the forecast period include innovation in patient engagement platforms, advancements in remote monitoring solutions, development of advanced cloud-based data management systems, progress in multi-parameter monitoring technologies, and the introduction of advanced data visualization tools.

The increasing adoption of remote patient monitoring is expected to drive the growth of the decentralized trial wearable kit market in the coming years. Remote patient monitoring involves the use of digital technologies and connected devices to continuously gather and transmit patients’ health data, such as vital signs or chronic condition indicators, to healthcare professionals. This enables timely medical interventions, improved care management, and reduced need for in-person visits. The growing use of remote patient monitoring is largely driven by enhanced patient convenience, as it allows continuous health tracking from home without frequent hospital visits. The decentralized trial wearable kit supports remote patient monitoring by providing wearable devices and digital tools that continuously record vital signs, physiological data, and activity levels, allowing healthcare providers to access real-time insights, ensure timely interventions, and improve trial efficiency while minimizing on-site visits. For example, in October 2024, according to a report by the World Health Organization, based in Switzerland, teleradiology was the most widely adopted service, reported in 84% of countries. Additionally, telemedicine and telepsychiatry were also expanding, with 77% of countries offering telemedicine or remote patient monitoring and 51% providing telepsychiatry services. Therefore, the increasing adoption of remote patient monitoring is fueling the growth of the decentralized trial wearable kit market.

Major companies in the decentralized trial wearable kit market are focusing on developing innovative technologies such as wireless data transmission to enhance data accuracy and streamline remote clinical trial operations. Wireless data transmission refers to the transfer of digital information between devices without physical cables, using technologies such as Wi-Fi, Bluetooth, or cellular networks to enable real-time communication, remote monitoring, and seamless connectivity across devices and locations. For instance, in June 2025, Empatica Inc., a US-based digital health company, introduced the EmbraceMini, the world’s smallest actigraphy wearable designed for clinical trials. This compact and comfortable device allows continuous monitoring of patients’ physiological data, enhancing data collection in decentralized and hybrid studies while improving patient comfort and trial efficiency. The launch aims to advance decentralized clinical trials by providing precise, continuous patient monitoring, reducing the need for frequent site visits, and enabling more efficient, data-driven decision-making throughout the study.

In May 2024, Medable Inc., a US-based technology company, partnered with Masimo Inc. to accelerate the decentralization and optimization of clinical trials. Through this collaboration, Medable aims to utilize Masimo’s advanced noninvasive monitoring technologies to improve the accuracy and efficiency of decentralized clinical trials by enabling real-time data collection, strengthening patient engagement, and streamlining remote study operations for faster and more reliable outcomes. Masimo Inc., based in California, is a consumer electronics company that develops patient monitoring devices and technologies, including noninvasive optical sensors, patient management systems, and telehealth solutions.

Major players in the decentralized trial wearable kit market are Dassault Systèmes SE, IQVIA Holdings Inc, THREAD Research Inc., ARCHIMED SAS, Google LLC, Alivecor Inc., ICON Public Limited Company, Oracle Corporation, Withings SAS, Clario Inc., Veeva Systems Inc., Koneksa Health Inc., Science 37 Holdings Inc., Medable Inc., Medidata Solutions Inc., Obvio Health USA Inc., ActiGraph LLC., Garmin Ltd., Signant Health Private Limited, Koninklijke Philips N.V.

North America was the largest region in the decentralized trial wearable Kit market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in decentralized trial wearable kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The decentralized trial wearable kit market research report is one of a series of new reports that provides decentralized trial wearable kit market statistics, including the decentralized trial wearable kit industry's global market size, regional shares, competitors with the decentralized trial wearable kit market share, detailed decentralized trial wearable kit market segments, market trends and opportunities, and any further data you may need to thrive in the decentralized trial wearable kit market. This decentralized trial wearable kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A decentralized trial wearable kit consists of digital health devices and tools designed to remotely monitor patients’ health and activity during clinical trials conducted outside conventional sites. It typically includes wearable sensors, mobile applications, and data transmission systems that gather real-time physiological and behavioral data. By facilitating decentralized or hybrid clinical trials, the kit improves patient convenience, reduces the need for site visits, and enhances data accuracy and consistency.

The primary product types of decentralized trial wearable kits include smartwatches, fitness bands, biosensors, smart clothing, and others. Smartwatches are multifunctional wearable devices that combine the functions of a traditional wristwatch with advanced digital technologies to monitor physical activity. These products are distributed through online and offline channels and are applied in areas such as clinical trials, remote patient monitoring, chronic disease management, and others. They are used by various end-users, including pharmaceutical companies, contract research organizations, hospitals, clinics, and others.

The countries covered in the decentralized trial wearable kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The decentralized trial wearable kit market consists of revenues earned by entities by providing services such as remote patient monitoring services, data collection and management services, clinical trial management services, regulatory compliance support services, logistics and supply management services, and data analytics services. The market value includes the value of related goods sold by the service provider or contained within the service offering. The decentralized trial wearable kit market also includes sales of wearable sensors, smartwatches, smart bands, mobile health kits, glucometers, and pulse oximeters. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.